Skip to content

Pharmacogenomics-Supported Psychotropic Prescribing Trial

Pharmacogenetics | Mental Disorder | Adverse Drug Reaction (ADR) | Effectiveness

Investigate the feasibility and utility of implementing pharmacogenetic testing for adults (aged 18 and older) seeking care for mental illness in Manitoba.

null

Participation Requirements

  • Sex:

    ALL

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:

* Aged 18 years or older
* The initiation, change, dose adjustment, or augmentation of psychotropic medication(s) is indicated
* The treating clinician thinks PGx testing can benefit and refers the patient to the study

Exclusion Criteria:

* Unwillingness to donate saliva samples for genetic analysis
* History of liver or bone marrow (hematopoietic cell) transplantation
* PGx testing results are already available
* No personal health identification number (PHIN) is available

Study Location

University of Manitoba College of Pharmacy
University of Manitoba College of Pharmacy
Winnipeg, Manitoba
Canada

Contact Study Team

Backup Contact

Mahin Hasan, MSc, BSc

[email protected]
Primary Contact

Abdullah Al Maruf, PhD, M.Pharm, B.Pharm

[email protected]
204-318-2575
Shared Health Facilities
Shared Health Facilities
Winnipeg, Manitoba
Canada

Contact Study Team

Primary Contact

Abdullah Al Maruf, PhD, M.Pharm, B.Pharm

[email protected]
204-318-2575
Study Sponsored By
University of Manitoba
Participants Required
More Information
Study ID: NCT06929533